Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intercept Pharma (DE:I4P)
FRANKFURT:I4P
Intercept Pharma (I4P) Stock Price & Analysis
1 Followers
I4P Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€8.16 - €19.97
Previous Close€17.52
Volume0.00
Average Volume (3M)128.00
Market Cap
€741.69M
Enterprise Value€649.43M
Total Cash (Recent Filing)$322.71M
Total Debt (Recent Filing)$223.86M
Price to Earnings (P/E)N/A
Beta0.69
Next Earnings
Feb 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,825,966
10 Day Avg. Volume7
30 Day Avg. Volume128
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)11.06
Price to Sales (P/S)8.25
Price to Cash Flow (P/CF)11.90
P/FCF Ratio12.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.04
Enterprise Value/Gross Profit2.28
Enterprise Value/Ebitda-19.26
Forecast
1Y Price Target
€17.73Price Target Upside1.21% Upside
Rating ConsensusHold
Number of Analyst Covering9
Intercept Pharma News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
10.50% Other Institutional Investors
89.50% Public Companies and
Individual Investors
I4P FAQ
What was Intercept Pharma’s price range in the past 12 months?
Intercept Pharma lowest stock price was €8.16 and its highest was €19.96 in the past 12 months.
What is Intercept Pharma’s market cap?
Currently, no data Available
When is Intercept Pharma’s upcoming earnings report date?
Intercept Pharma’s upcoming earnings report date is Feb 29, 2024 which is 64 days ago.
How were Intercept Pharma’s earnings last quarter?
Intercept Pharma released its earnings results on Nov 01, 2023. The company reported -€0.062 earnings per share for the quarter, beating the consensus estimate of -€0.223 by €0.161.
Is Intercept Pharma overvalued?
According to Wall Street analysts Intercept Pharma’s price is currently Undervalued.
Does Intercept Pharma pay dividends?
Intercept Pharma does not currently pay dividends.
What is Intercept Pharma’s EPS estimate?
Intercept Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intercept Pharma have?
Currently, no data Available
What happened to Intercept Pharma’s price movement after its last earnings report?
Intercept Pharma reported an EPS of -€0.062 in its last earnings report, beating expectations of -€0.223. Following the earnings report the stock price went up 0.424%.
Which hedge fund is a major shareholder of Intercept Pharma?
Among the largest hedge funds holding Intercept Pharma’s share is Deerfield Management Company, LP. It holds Intercept Pharma’s shares valued at 23M.
---
Intercept Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€17.73 (1.21% Upside)
€17.73 (1.21% Upside)
Blogger Sentiment
Neutral
DE:I4P Sentiment 50%
Sector Average 69%
Sector Average 69%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
-64.63%
Trailing 12-Months
Asset Growth
-29.72%
Trailing 12-Months
Company Description
Intercept Pharma
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.
---
I4P Stock 12 Months Forecast
Average Price Target
€17.73
▲(1.21% Upside)
Technical Analysis
Best Analysts Covering I4P
1 Year
1 Year Success Rate
10/27 ratings generated profit
1 Year Average Return
-3.06%
assigned a buy rating 7 months ago
Copying Brian Skorney's trades and holding each position for 1 Year would result in 37.04% of your transactions generating a profit, with an average return of -3.06% per trade.
---